Status:
UNKNOWN
Observational Study of Analgesia and Cost-efficiency of Analgetic Medication Pumps (Zalviso and PCA-syringe Pump (PCA=Patient Controlled Analgesia)) After Urogenital Intervention at the Clinical Daily Routine
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Analgesic Quality
Mobility
Eligibility:
All Genders
18-85 years
Brief Summary
The observational study will check if there is a difference in the postoperative care of patients with urogenital intervention while using the standard PCA-syringe pump or using the Zalviso sufentanyl...
Eligibility Criteria
Inclusion
- Patients after urological interventions with no indication of an periduralanästesia
- Patients compliant for a PCA system, and complied with the analysis of their data
Exclusion
- F03 dementia
- F10.2 dependence syndrome alcohol
- F11.2 dependence syndrome opioids
- F12.2 dependence syndrome cannabinoids
- F13.2 dependence syndrome sedatives and hypnotics
- F14.2 dependence syndrome cocaine
- F15.2 dependence syndrome coffin
- F.16.2 dependence syndrome hallucinogens
- F22 schizophrenia
- F41.1 generalized anxiety disorder
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03355352
Start Date
November 1 2017
End Date
December 1 2018
Last Update
November 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Tuebingen, clinic of anästhesiology and intensiv care
Tübingen, Germany, 72074